TotalMarketCap

Kiora Pharmaceuticals

KPRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$6.637 M

$1.50 -9.64%

Close of 6 Nov 2026

As of 6 Nov 2026, Kiora Pharmaceuticals (KPRX) has a market capitalization of $6.64M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$10.8K

Loss-making

Shares outstanding

4,424,387

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #437ImmuronIMRN$6.70M
  2. #438Ensysce BiosciencesENSC$6.65M
  3. #439Kiora PharmaceuticalsKPRX$6.64M
  4. #440FibroBiologicsFBLG$6.36M
  5. #441Enveric BiosciencesENVB$6.36M

What if Kiora Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$6,382,098

Per share 4,254,732× higher

Bitcoin $1.53T

$345,324.21

Per share 230,216× higher

Apple $5.02T

$1,133,667

Per share 755,778× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Kiora Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.